Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Allergic rhinitis (disorder) (Disease Or Phenotype)

Omim:607154

Nci:C79532

Msh:D065631

Mondo:MONDO:11786

Medcin:MEDCIN:30791

Mdr:MDR:10001723

Id:36cc1e27-6a23-53f3-8fdf-2274b038bf69

Icpc2icd10eng:MTHU064936

Icd10cm:J30.9

Efo:EFO:5854

Doid:DOID:4481

Chv:CHV:911

Results found

Linked to

	Label	Description
	Budesonide indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Bilastine indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tranilast indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fluticasone indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Potassium Iodide indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Azatadine indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	SID11111652 indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	paracetamol indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	3-[(R)-3-(4-Fluoro-benzenesulfonylamino)-1,2,3,4-tetrahydro-carbazol-9-yl]-propionic acid indication Allergic rhinitis (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Budesonide indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Bilastine indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Tranilast indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fluticasone indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Potassium Iodide indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Azatadine indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

SID11111652 indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

paracetamol indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

3-[(R)-3-(4-Fluoro-benzenesulfonylamino)-1,2,3,4-tetrahydro-carbazol-9-yl]-propionic acid indication Allergic rhinitis (disorder)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.